GB1397893A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1397893A GB1397893A GB2649273A GB2649273A GB1397893A GB 1397893 A GB1397893 A GB 1397893A GB 2649273 A GB2649273 A GB 2649273A GB 2649273 A GB2649273 A GB 2649273A GB 1397893 A GB1397893 A GB 1397893A
- Authority
- GB
- United Kingdom
- Prior art keywords
- june
- pharmaceutical compositions
- edetate
- carboxypoylmethylene
- waterwhite
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26118672A | 1972-06-09 | 1972-06-09 | |
| US26774372A | 1972-06-30 | 1972-06-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1397893A true GB1397893A (en) | 1975-06-18 |
Family
ID=26948452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB2649273A Expired GB1397893A (en) | 1972-06-09 | 1973-06-04 | Pharmaceutical compositions |
Country Status (8)
| Country | Link |
|---|---|
| CA (1) | CA1014856A (cg-RX-API-DMAC7.html) |
| DE (1) | DE2329130A1 (cg-RX-API-DMAC7.html) |
| FR (1) | FR2187340B1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB1397893A (cg-RX-API-DMAC7.html) |
| IE (1) | IE37718B1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL42365A (cg-RX-API-DMAC7.html) |
| NL (1) | NL7307072A (cg-RX-API-DMAC7.html) |
| PH (1) | PH10968A (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0112852B1 (en) * | 1982-06-24 | 1988-06-08 | SMITH, Robert Alan | Pharmaceutical gel composition |
| DE69029804T2 (de) * | 1989-06-07 | 1997-09-04 | Gail S Bazzano | VEHIKEL MIT LANGSAMER FREISETZUNG ZUR VERMINDERUNG DER HAUTREIZUNG TOPISCHER retinoidhaltiger MITTEL |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK135267A (cg-RX-API-DMAC7.html) * | 1971-02-25 | |||
| BE786884A (fr) * | 1971-07-30 | 1973-01-29 | Merck & Co Inc | Pyrazole steranique et procede |
-
1973
- 1973-05-21 NL NL7307072A patent/NL7307072A/xx not_active Application Discontinuation
- 1973-05-28 IL IL42365A patent/IL42365A/en unknown
- 1973-05-29 CA CA172,696A patent/CA1014856A/en not_active Expired
- 1973-05-29 PH PH14666A patent/PH10968A/en unknown
- 1973-05-29 IE IE858/73A patent/IE37718B1/xx unknown
- 1973-06-04 GB GB2649273A patent/GB1397893A/en not_active Expired
- 1973-06-06 FR FR7320537A patent/FR2187340B1/fr not_active Expired
- 1973-06-07 DE DE2329130A patent/DE2329130A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU5625573A (en) | 1974-12-05 |
| CA1014856A (en) | 1977-08-02 |
| IL42365A (en) | 1977-04-29 |
| FR2187340A1 (cg-RX-API-DMAC7.html) | 1974-01-18 |
| FR2187340B1 (cg-RX-API-DMAC7.html) | 1976-10-22 |
| IE37718L (en) | 1973-12-09 |
| IL42365A0 (en) | 1973-07-30 |
| PH10968A (en) | 1977-10-18 |
| IE37718B1 (en) | 1977-09-28 |
| DE2329130A1 (de) | 1973-12-20 |
| NL7307072A (cg-RX-API-DMAC7.html) | 1973-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2263183T3 (es) | Una composicion de gel a base de nitroimidazol. | |
| HUP9902121A2 (hu) | Gonadotropin-leadó hormon antagonista hatású indolszármazékok és ezeket a vegyületeket tartalmazó gyógyszerkészítmények | |
| IE831611L (en) | Topical anti-inflammatory compositions | |
| IL102814A0 (en) | Pyrazine derivatives,their preparation and pharmaceutical compositions comprising them | |
| IE35177B1 (en) | Improvements in or relating to uracil derivatives | |
| GB1455487A (en) | Pharmaceutical compositions | |
| HUT49614A (en) | Process for producing cefalosporin derivatives and pharmaceutical compositions comprising these compounds | |
| ES427079A1 (es) | Un metodo de preparacion de fenotiazidas sustituidas por fluor en la posicion 7. | |
| IE35811B1 (en) | Diazepine derivatives and a process for their manufacture | |
| US3230143A (en) | Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine | |
| IE37250L (en) | Triazolobenzodiazepines | |
| IE37718B1 (en) | Pharmaceutical compositions | |
| IE44339L (en) | Piperazine derivatives. | |
| RU95110110A (ru) | Производные бензофурана, способ их получения, фармкомпозиция и способ лечения | |
| EP0867181A1 (en) | Nasal melatonin composition | |
| EP0302836B1 (en) | Pharmaceutical compositions for topical use containing miocamycin | |
| ES471993A1 (es) | Procedimiento de preparacion de nuevos derivados de alcaloi-des pentaciclicos | |
| GB1470355A (en) | Pharmaceutical compositions | |
| GB1455552A (en) | Pharmaceutical composition for topical administration | |
| GB1453234A (en) | Liquid vehicle for pharmaceutical compositions | |
| GB1270049A (en) | New pharmaceutical product | |
| EP0056681A3 (en) | Levonantradol and n-methyllevonantradol formulations | |
| GB1125349A (en) | Soluble salts of ellagic acid | |
| GB1446237A (en) | Pharmaceutical preparations containing pyrazolones | |
| GB1397675A (en) | Proline compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |